Cargando…

Nicotine-induced adrenal beta-arrestin1 upregulation mediates tobacco-related hyperaldosteronism leading to cardiac dysfunction

BACKGROUND: Tobacco-related products, containing the highly addictive nicotine together with numerous other harmful toxicants and carcinogens, have been clearly associated with coronary artery disease, heart failure, stroke, and other heart diseases. Among the mechanisms by which nicotine contribute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cora, Natalie, Ghandour, Jennifer, Pollard, Celina Marie, Desimine, Victoria Lynn, Ferraino, Krysten Elaine, Pereyra, Janelle Marie, Valiente, Rachel, Lymperopoulos, Anastasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283997/ https://www.ncbi.nlm.nih.gov/pubmed/32547713 http://dx.doi.org/10.4330/wjc.v12.i5.192

Ejemplares similares

OR24-03 GRK2 Mediates Beta-Adrenergic Receptor Crosstalk to Enhanced Adrenocortical AngII-Dependent Aldosterone Production
por: Lymperopoulos, Anastasios, et al.
Publicado: (2020)

GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo
por: Pollard, Celina M., et al.
Publicado: (2020)

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility
por: Maning, Jennifer, et al.
Publicado: (2022)

Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart
por: Lymperopoulos, Anastasios, et al.
Publicado: (2019)

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
por: Maning, Jennifer, et al.
Publicado: (2020)

Correction: Maning et al. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition. Int. J. Mol. Sci. 2020, 21, 2868
por: Maning, Jennifer, et al.
Publicado: (2021)

Adrenal βarrestin1 targeting for tobacco–associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link
por: Solesio, Maria E, et al.
Publicado: (2019)

GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone
por: Pollard, Celina M, et al.
Publicado: (2022)

PMON181 RGS4 Is Essential For The Sympathetic Regulation of The Short-chain Fatty Acid Receptor FFAR3 In The Heart
por: Carbone, Alexandra, et al.
Publicado: (2022)

Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy
por: Lymperopoulos, Anastasios, et al.
Publicado: (2017)

Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison
por: Dabul, Samalia, et al.
Publicado: (2015)

LBODP014 Hyperaldosteronism Caused By Adrenal Cyst
por: Vargas, Laura Valentina Estupiñan, et al.
Publicado: (2022)

Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease
por: Parker, Barbara M., et al.
Publicado: (2018)

Coincidence of Large Adrenal Cyst and Prominent Hyporeninemic Hyperaldosteronism
por: Sakaue, Takaaki, et al.
Publicado: (2021)

Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism
por: Naruse, Mitsuhide, et al.
Publicado: (2021)

βArrestins in Cardiac G Protein-Coupled Receptor Signaling and Function: Partners in Crime or “Good Cop, Bad Cop”?
por: Lymperopoulos, Anastasios, et al.
Publicado: (2013)

Anomalous adrenal vein anatomy complicating the evaluation of primary hyperaldosteronism
por: Ford, Kaitlin M., et al.
Publicado: (2017)

Hyperaldosteronism from a large adrenal adenoma in a patient with bilateral adrenal nodules
por: Adapa, Sreedhar, et al.
Publicado: (2019)

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland
por: Lymperopoulos, Anastasios, et al.
Publicado: (2021)

Regulator of G-Protein Signaling-4 Attenuates Cardiac Adverse Remodeling and Neuronal Norepinephrine Release-Promoting Free Fatty Acid Receptor FFAR3 Signaling
por: Carbone, Alexandra M., et al.
Publicado: (2022)

A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenoma
por: Wang, Wei, et al.
Publicado: (2019)

Deletion of Osteopontin Enhances β(2)-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes
por: Pollard, Celina M., et al.
Publicado: (2019)

Case report: schwannoma arising from the unilateral adrenal area with bilateral hyperaldosteronism
por: Babaya, Naru, et al.
Publicado: (2017)

SAT-LB301 Hyperaldosteronism From Adrenal Adenoma in a Young Patient
por: Maldonado, Francisco Javier Lopez, et al.
Publicado: (2020)

Adrenal Vein Sampling in a Patient With Primary Hyperaldosteronism and Severe Contrast Allergy
por: Prins, Margaretha L M, et al.
Publicado: (2021)

Adrenal Vein Sampling to Distinguish Between Unilateral and Bilateral Primary Hyperaldosteronism: To ACTH Stimulate or Not?
por: Sung, Tae-Yon, et al.
Publicado: (2020)

Gynaecomastia in a male neutered cat with an adrenal tumour and associated hyperprogesteronism, hypercortisolism and hyperaldosteronism
por: Yu, Jane, et al.
Publicado: (2021)

Neuroblastoma accompanied by hyperaldosteronism
por: Gulleroglu, Kaan, et al.
Publicado: (2014)

Cone-beam computed tomography is not a mandatory procedure in adrenal venous sampling for primary hyperaldosteronism
por: Cai, Ran, et al.
Publicado: (2022)

SUN-202 Is a “Failed” Adrenal Venous Sampling Useful for Surgical Decision Making in Primary Hyperaldosteronism?
por: El Mais, Rania, et al.
Publicado: (2020)

Adrenal venous sampling in primary hyperaldosteronism: correlation of hormone indices and collimated C-arm CT findings
por: Becker, L. S., et al.
Publicado: (2021)

Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study
por: Takizawa, Nae, et al.
Publicado: (2021)

The place of ARBs in heart failure therapy: is aldosterone suppression the key?
por: Markan, Uma, et al.
Publicado: (2019)

Structure–activity relationship study of angiotensin II analogs in terms of β‐arrestin‐dependent signaling to aldosterone production
por: Valero, Thairy Reyes, et al.
Publicado: (2016)

Nicotin in Tobacco
Publicado: (1913)

Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study
por: Sigurjonsdottir, Helga Agusta, et al.
Publicado: (2012)

Does it come from tobacco? Young adults’ interpretations of the term “tobacco-free nicotine” in a cross-sectional national survey sample
por: Morean, Meghan E., et al.
Publicado: (2022)

Changes in the Perceived Epidemiology of Primary Hyperaldosteronism
por: Fagugli, Riccardo Maria, et al.
Publicado: (2011)

Primary hyperaldosteronism: challenges in subtype classification
por: Layden, Brian T, et al.
Publicado: (2012)

An Association of Chronic Hyperaldosteronism with Medullary Nephrocalcinosis
por: Mittal, Kartik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eire90olakgbk9cl5hup44o1j2